Thomas Jefferson University

Jefferson Digital Commons
Department of Medicine Faculty Papers

Department of Medicine

March 2008

Solid serous adenoma of the pancreas: a rare form of serous
cystadenoma
Madhusudhan R. Sanaka
Thomas Jefferson University

Thomas E. Kowalski
Thomas Jefferson University

Corey Brotz
Thomas Jefferson University

Charles J. Yeo
Thomas Jefferson University

Peter McCue
Thomas Jefferson University
Follow this and additional works at: https://jdc.jefferson.edu/medfp
Part of the Medical Genetics Commons
See next page for additional authors

Let us know how access to this document benefits you
Recommended Citation
Sanaka, Madhusudhan R.; Kowalski, Thomas E.; Brotz, Corey; Yeo, Charles J.; McCue, Peter; and
Palazzo, Juan, "Solid serous adenoma of the pancreas: a rare form of serous cystadenoma"
(2008). Department of Medicine Faculty Papers. Paper 29.
https://jdc.jefferson.edu/medfp/29
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital
Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is
a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections
from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested
readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been
accepted for inclusion in Department of Medicine Faculty Papers by an authorized administrator of the Jefferson
Digital Commons. For more information, please contact: JeffersonDigitalCommons@jefferson.edu.

Authors
Madhusudhan R. Sanaka, Thomas E. Kowalski, Corey Brotz, Charles J. Yeo, Peter McCue, and Juan
Palazzo

This article is available at Jefferson Digital Commons: https://jdc.jefferson.edu/medfp/29

Solid serous adenoma of the pancreas, a rare form of serous cystadenoma

Madhusudhan R. Sanaka, Thomas E. Kowalski, Corey Brotz, Charles J. Yeo,
Peter McCue and Juan Palazzo

Introduction:
Serous cystadenomas (SC) of the pancreas are uncommon benign cystic
neoplasms that were first differentiated from mucinous cystadenomas in 1978 by
Compagno and Oertel (1-3). Serous cystadenomas characteristically have a spongy gross
appearance and are composed of innumerable tiny cysts lined by flattened cuboidal or
polygonal cells with clear to pale eosinophilic cytoplasm atop of thin fibrous septae.
Since 1978, five unique SC subtypes have been identified (4-5). Here we report a case of
a solid serous adenoma, a rare serous cystadenoma subtype.
Case report:
A 74 year-old man was incidentally found to have a pancreatic mass during an
evaluation for renal colic. An abdominal CT scan revealed a 1.5 cm diameter, enhancing
mass in the anterior aspect of the body of the pancreas (Figure 1). An endoscopic
ultrasound demonstrated a 1.9 x 1.3 cm well circumscribed, hypoechoic mass (Figure 2).
The pancreatic parenchyma appeared normal as did the adjacent vascular structures.
There was no peripancreatic or celiac axis lympadenopathy. Fine needle aspiration of the
mass was performed, but the specimen was found to be inadequate for cytologic
evaluation. Concern for malignancy prompted surgical consultation and plan for surgical
resection. Intraoperatively, the mass was found to be encapsulated and was enucleated.
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Due to the proximity of the resection cavity to the main pancreatic duct, the cavity was
drained via a Roux-en-Y pancreaticojejunostomy. Gross pathology demonstrated a 1.6 x
1.3 cm well-demarcated solid mass (Figure 3). Microscopic study showed an
encapsulated tumor composed of vague nodules with dense collagenous septa (Figure 4).
The tumor cells had small round nuclei and clear or pale amorphophilic cytoplasm
(Figure 5). There was no necrosis, cytologic atypia, or abnormal mitotic figures. Some
tumor cells contained glycogen granules as demonstrated by periodic acid-Schiff (PAS)
staining. Immunohistochemical staining revealed tumor cells positive for cytokeratin
CAM 5.2 and negative for synaptophysin and chromogranin. The tumor was diagnosed
as a solid serous adenoma of the pancreas. The patient recovered uneventfully and was
discharged home on postoperative day 5. The patient was seen two month postoperatively and was fully recovered.
Discussion:
Solid serous adenoma of the pancreas is an extremely rare benign tumor of the
pancreas. The tumor was first described in 1996 (1) as a solid pancreatic tumor composed
of cells morphologically and histochemically indistinguishable from those of SC, and was
therefore thought to represent a solid SC variant. The second report published in 2004,
confirmed the existence of a solid pancreatic tumor with cells morphologically and
immunohistochemically indistinguishable from those of SC and distinct from other
known solid tumors of the pancreas, supporting solid serous adenoma as a SC subtype (2).
It is postulated that the cells of solid serous adenoma are SC cells that lack
secretory capability and it is the secretion of serous fluid that imparts the cystic
architecture to serous cystadenomas (1).

Solid serous adenomas are therefore well-circumscribed tumors formed by clear
to pale polygonal to cuboidal cells arranged in nests, sheets, and trabeculae separated by
thick fibrous bands. Although small acini with glandular spaces may be present, cystic
spaces are absent. PAS and PAS-diastase stains show abundant cytoplasmic glycogen.
Histologically, the differential diagnosis includes the rare primary clear-cell "sugar"
tumor of the pancreas, clear cell carcinoma, clear cell islet cell tumor, and metastatic
renal cell carcinoma (1). These other rare solid tumors of the pancreas are excluded on
immunohistochemical bases. As such, solid serous adenomas are immunoreactive for
CAM 5.2, epithelial membrane antigen, and neuron-specific enolase but negative for
HMB-45, synaptophysin, chromogranin, insulin, glucagon pancreatic peptide, gastrin,
somatostatin,vasoactive intestinal polypeptide, serotonin, bombesin, calcitonin, lipase 21,
lipase 105, chymotrypsin, and trypsin.
Similar to other pancreatic incidentalomas, solid serous adenomas are usually
asymptomatic and incidental findings on imaging studies performed for other reasons (6).
The rarity of these tumors, the difficulty in achieving a definitive preoperative diagnosis,
and the potential for malignancy invariably leads to the recommendation for surgical
excision. Accordingly, our patient underwent surgery with enucleation of a wellencapsulated tumor and no evidence of residual or metastatic disease. He is
asymptomatic after six months. In two of the previously reported cases, patients were
well at 1 and 5 years post-operatively (1-2). Similarly, we expect our patient to continue
to do well. In conclusion, solid serous adenoma is an extremely rare, benign pancreatic
tumor with solid architecture but cytologic, histochemical, and immunohistochemical
features identical to that of serous cystadenoma.
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Figures & Legends
Figure 1
Abdominal CT scan showing 1.5-cm hypervascular arrow) in the anterior aspect of
the body of the pancreas

Figure 2
Endoscopic ultrasound showing 1.9-× 1.3-cm hypoechoic mass (arrow) in the
body of the pancreas

Figure 3
Gross surgical specimen demonstrating a well-demarcated solid mass.

Figure 4
Low-power microscopy revealing an encapsulated tumor composed of nodules and dense
collagenous septa (hematoxylin and eosin; original magnification, ×10)

Figure 5
High-power microscopy showing bland appearing cuboidal cells with small round nuclei
and pale eosinophilic cytoplasm (hematoxylin and eosin; original magnification, ×40)

